Ann: Trading Halt, page-72

First 72 Last

Share
Profile

Follow
Brickingbad

3,134 Posts.

110

14/12/21

14:26

Post #: 58284263
Share

Originally posted by PipZigg: ↑

This has just been posted by the Australian Manufacturing Forum. An interesting read and pretty much what I think we are all thinking ..... the second half is in line with most of or comments!

1.5 YEARS AFTER STARTING A PROCESS, CANBERRA BACKS COMMERCIAL MRNA VACCINE MANUFACTUREBy Peter RobertsPrime Minister Scott Morrison announced today that state and federal governments and vaccine producer Moderna had signed an ‘in-principal’ deal for the construction of a Melbourne plant capable of utilising the newly successful vaccine production technologies that produced the Pfizer and Moderna vaccines.The plant would be capable of producing up to 100 million shots a year and was an investment in the future.Morrison said: “This investment will continue to secure Australia’s future economic prosperity while protecting lives by providing access to world-leading mRNA vaccines made on Australian soil.“The new mRNA manufacturing facility in Victoria will produce respiratory vaccines for potential future pandemics and seasonal health issues such as the common flu, protecting lives and livelihoods.”The announcement is great news, but perhaps I am too cynical of announcements made by Morrison who is clearly in election, and daily announcement, mode.This one comes more that 18 months after the government began investigation of local manufacture of mRNA vaccines and the PM gave scant details of the proposed arrangement.The site of the factory was not revealed, nor was its cost or the state subsidies required.

While Morrison spoke at Melbourne’s Doherty Institute, he made no mention of any Australian companies being involved.However the two most likely Victorian vaccine collaborators, CSL and IDT Australia are both on trading halts on the ASX today.There is no apparent reason for IDT’s halt, but CSL’s may be to do with a potential deal with Swiss-based Vifor Pharma.CSL had its own proposal to build a mRNA facility before the government and would be disappointed should it miss out to a foreign producer.In this case the words ‘in principal’, which were reported by The Australian newspaper, may turn out to be the operative word because like all deals they are not real until final contracts are made.However Moderna Australia General Manager Michael Aztrak and Victoria’s Acting Premier James Merlino have made comments supporting the announcement, lending it weight.Perhaps then, this is just an announcement by a government in election mode looking to make announcements often, and early.Canberra has already backed pilot manufacture of Australia’s own home-grown mRNA vaccine developed by researchers at Monash University.To be manufactured at IDT Australia in Melbourne, clinical trials are planned to start in January.Canberra has backed that project to the tune of $11.5 million.

Expand

i believe the 11.5 mil is to bring the facility sterile ready, not for the Monash vaccine, they get another 2mil for it.

correct me if I'm wrong

IDT Price at posting: 48.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 88 more messages in this thread...

First 72 Last

Add IDT (ASX) to my watchlist

(20min delay)
Last 9.6¢		Change 0.000(0.00%)		Mkt cap ! $33.74M

Open	High	Low	Value	Volume
9.7¢	9.7¢	9.6¢	$9.694K	100.9K

Buyers (Bids)

No.	Vol.	Price($)
3	50002	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
9.7¢	34000	1

View Market Depth

No.	Vol.	Price($)
3	50002	0.096
4	297709	0.095
2	218001	0.094
2	93763	0.093
1	30000	0.092

Price($)	Vol.	No.
0.097	34000	1
0.098	10295	1
0.099	27375	2
0.100	54350	4
0.105	344000	3

Last trade - 11.59am 27/05/2024 (20 minute delay)


Last 9.6¢		Change 0.000 ( 0.10 %)
Open	High	Low	Volume
9.7¢	9.7¢	9.6¢	20048
Last updated 11.59am 27/05/2024 ?

IDT (ASX) Chart

Ann: Trading Halt, page-72

Featured News

Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans

High-grade gossans with VMS potential impress Dreadnought in WA

Week 21 Wrap: NVIDIA's profits are up 600% – but this time, the market didn't really care

Historical prospects impress Solstice, with 25% copper and significant anomaly

Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-72

Featured News

Top Stories

Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans

High-grade gossans with VMS potential impress Dreadnought in WA

Week 21 Wrap: NVIDIA's profits are up 600% – but this time, the market didn't really care

Historical prospects impress Solstice, with 25% copper and significant anomaly

Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market

Buyers (Bids)

Sellers (Offers)

Featured News